amfAR Analysis: Sequestration for Global Health Programs Isn't Worth the Cost
Research!America’s report on sequestration detailed the devastating impact that the sequester, or across-the-board cuts that are scheduled to take place in 2013, will have on federally funded research to improve health. Now, a recent report by amfAR trains the focus of sequestration on global health.
Just as we found, amfAR reaches the same conclusion: Sequestration isn’t worth the cost.
The cuts would save $689 million ’ or 0.63% of the required deficit reduction for FY13. And at what cost?
- HIV/AIDS treatment for 273,000 fewer people, potentially leading to 62,000 more deaths
- Malaria treatment for 3.7 million fewer people, potentially leading to nearly 6,000 more deaths
- TB treatment for 65,000 fewer people, potentially leading to 8,000 more deaths
- Reduced funding for the GAVI Alliance, potentially resulting in 13,000 more deaths from diptheria, tetanus, pertussis, hib and hepatitis B
That’s hardly all. Besides an increase in the death rate, critical interventions will never get a chance to prevent disease: antiretroviral drugs that prevent transmission of HIV from a pregnant mother to her child and insecticide-treated nets to prevent bites from malaria-infected mosquitoes.
And that has consequences further down the line, the report notes.
“The savings achieved in across-the-board cuts in global health funding will have a negligible impact on deficit reduction,” the report states, “but will adversely affect the lives of millions of men, women and children worldwide, resulting in substantial human suffering and squandering of opportunities to build on successes in U.S. global health programming.”
Your voice can make a difference, however. Click here to contact your representatives, and tell them that sequestration is an unacceptable outcome.
amfAR is a Research!America member.